Vaccination remains the strongest defense against COVID-19. For more information about where you can schedule a vaccine, be tested for COVID-19 or learn more about the virus, visit https://www.bjc.org/coronavirus

COVID-19 Information
Select the search type
  • Site
  • Web
Go

UNMASKING HIGH-RISK BREAST TUMORS

A unique genetic signature can alert physicians to high-risk breast tumors that masquerade as low-risk tumors, according to research at the Siteman Cancer Center and collaborating national cancer centers. Although these tumors appear to be estrogen-receptor-positive – meaning they should depend on the hormone estrogen to grow – they don’t respond well to anti-estrogen therapy. “These tumors are like wolves in sheep’s clothing,” says Matthew Ellis, MB, BChir, PhD, a Washington University medical oncologist at Siteman.

A clinical test for the high-risk gene signature will be widely available soon. The test, Ellis says, will help physicians identify women who would benefit from more aggressive treatment suited to this tumor type.

Find a doctor or make an appointment: 866.867.3627
General Information: 314.747.3000
One Barnes-Jewish Plaza
St. Louis, MO 63110
© Copyright 1997-2022, Barnes-Jewish Hospital. All Rights Reserved.